麻醉与镇痛方式与髋部骨折术后长期死亡率的关系:澳新髋部骨折登记分析
基于澳新髋部骨折登记2016–2018年数据,纳入17,635例髋部骨折手术患者,随访至少12个月。12个月死亡率为30.6%(n=5410);椎管内麻醉与全麻的12个月死亡率无差异(p=0.238);全麻联合椎管内麻醉与较高12个月死亡率独立相关;急诊与手术室均行神经阻滞与长期死亡率降低相关。
要点
- 椎管内麻醉与全麻的12个月死亡率无差异
- 全麻联合椎管内麻醉与12个月死亡率升高独立相关
- 急诊与手术室均行神经阻滞与长期死亡率降低相关
核心结论
- 椎管内麻醉与全麻在髋部骨折手术12个月死亡率上无差异。
- 同一手术中联合使用全麻与椎管内麻醉与较高12个月死亡率风险相关。
- 急诊与手术室均行区域神经阻滞与较低12个月及更长期死亡率风险相关。
研究设计与样本
- 回顾性分析澳大利亚与新西兰髋部骨折登记2016–2018年数据,随访至少12个月,共17,635例患者。
主要发现
- 12个月死亡率为30.6%(n=5410)。
- 椎管内麻醉与全麻的12个月死亡率差异无统计学意义(p=0.238)。
- 全麻联合椎管内麻醉为较高12个月死亡率的独立预测因素(未校正完整病例HR=1.17,95%CI 1.04–1.31;p<0.001)。
- 急诊与手术室均行神经阻滞与长期死亡率降低相关(中位随访21个月,未插补未校正HR=0.86,95%CI 0.77–0.96;p=0.043)。
临床怎么用
- 髋部骨折手术选择椎管内麻醉或全麻时,12个月死亡率无差异。
- 应避免不必要的全麻联合椎管内麻醉组合,因其与较高12个月死亡率相关。
- 急诊与手术室均实施区域神经阻滞可能有助于降低长期死亡率风险。
局限性
- 原文指出这些发现的原因尚不清楚,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Hip fractures are a common frailty injury affecting a vulnerable geriatric population. It is debated if anesthetic and analgesic techniques are associated with altered risk for outcomes in hip fracture patients. This study aimed to determine the association of anesthesia and regional analgesia with all cause 12-month mortality and even longer-term mortality after hip fracture surgery in Australia and New Zealand. METHODS: Data from the Australian and New Zealand Hip Fracture Registry collected from 2016 to 2018, with a minimum follow-up of 12 months, were reviewed. Anesthesia type and use of regional nerve blocks were investigated. The primary outcome was all cause 12-month mortality. RESULTS: 12-month mortality was 30.6% (n=5410) in a total of 17,635 patients. There was no difference in 12-month mortality between patients who received spinal or general anesthesia (p=0.238). The administration of a combination of general and spinal anesthesia for surgery to repair the fracture was an independent predictor of higher 12-month mortality (unadjusted complete case HR=1.17 (95% CI 1.04 to 1.31); p<0.001). Nerve blocks performed in both the emergency department (ED) and the operating theater (OT) were associated with reduced long-term mortality (median follow-up 21 months) with an unimputed unadjusted HR=0.86 (95% CI 0.77 to 0.96; p=0.043). CONCLUSION: There was no difference in the association of 12-month mortality between general and spinal anesthesia in patients undergoing hip fracture surgery. However, there was an association with a higher risk of 12-month mortality in patients who received both general and spinal anesthesia for the same surgery. Patients who received a regional nerve block in both the ED and the OT had a lower association of 12-month and longer-term mortality risk. The reasons for these findings remain unknown and should be the subject of further research investigation.
引用
- Lin DY, Woodman R, Oberai T, et al. Association of anesthesia and analgesia with long-term mortality after hip fracture surgery: an analysis of the Australian and New Zealand hip fracture registry. Reg Anesth Pain Med. 2022. PMID: 36137734. doi:10.1136/rapm-2022-103550
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。